pharmaphorum
JANUARY 4, 2021
Jennifer Haas, executive vice president of Noteworth, shares her 2021 predictions surrounding the future of telehealth and big data. . The ability to use big data in healthcare through digital medicine will prove to be invaluable for healthcare organisations as they work through the pandemic and the new world it has created.
pharmaphorum
JANUARY 24, 2022
Exploring the Impact of Machine Learning and Artificial Intelligence in Drug Development from Discovery to Healthcare. AI in drug discovery is becoming an integral part of the research and development area of treating diseases with more companies incorporating ‘Big Data’ and data scientists within their R&D teams.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 1, 2022
His research focuses on the development of big data machine learning for tracking the health of complex systems. He has carried a drug candidate continuously from early preclinical development throughout to market authorisation with an innovative application strategy, including a novel and innovative real-world data approach.
Pharmaceutical Technology
NOVEMBER 9, 2022
According to a recent GlobalData report, healthcare professionals have – for the second year in a row – ranked artificial intelligence (AI) and Big Data as the top two technologies revolutionising the pharmaceutical sector. Access to detailed data in real time enables firms to track and optimize product storage and distribution.
pharmaphorum
FEBRUARY 11, 2022
Instead, Komodo’s software is the gateway to the Map’s data. One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”. The business of data. Our software is deployed across two dimensions. About the author.
pharmaphorum
MAY 30, 2022
The company developed the first FDA-authorised at-home VR pain treatment, RelieVRx, indicated as an adjunctive treatment for chronic lower back pain. He oversees operations, including business development, sales and marketing, and people. Distinct offerings. AppliedVR creates VR-based treatments aimed at relieving chronic pain.
The Pharma Data
JANUARY 4, 2021
Kiromic’s deep understanding of the tumor micro environment (TME) and the tumors’ escape and masking mechanisms led to development of a promising platform for chimeric antigen receptor therapy (CAR-T). PD-1 has always been a challenge for CAR-T development. “We believe Prof. About PD-1 Check-point inhibition.
Expert insights. Personalized for you.
111 
Let's personalize your content